We are looking for individuals who have Alzheimer’s Disease for a study of an investigational medication designed to slow the progression of Alzheimer’s disease. To be eligible, participants must:
QR Code Link to This Post
Be 55 to 80 years of age
Have been diagnosed with Alzheimer’s disease
Have an MRI or CT scan that was performed after the Alzheimer’s disease diagnosis
Have a study partner who can attend appointments
Eligible participants will receive study-related care, monitoring and investigational medication or placebo. Compensation for time and travel may be available to patient and caregiver.
For more information or to schedule a memory screening for this study, call Meridien Research today at show contact info
or complete the form below to see if you qualify!
post id: 6853054996
email to friend